SWITCH II Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Pa… (NCT05041114) | Clinical Trial Compass
WithdrawnNot Applicable
SWITCH II Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis
Stopped: Study moved to U.S.
Australia0Started 2022-04-21
Plain-language summary
The Synchron Motor Neuroprosthesis (MNP) is intended to be used in subjects with severe motor impairment, unresponsive to medical or rehabilitative therapy and a persistent functioning motor cortex. The purpose of this research is to evaluate safety and feasibility.
The MNP is a type of implantable brain computer interface which bypasses dysfunctional motor neurons. The device is designed to restore the transmission of neural signal from the cerebral cortex utilized for neuromuscular control of digital devices, resulting in a successful execution of non-mechanical digital commands.
Who can participate
Age range18 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Severe motor impairment
✓. Able to give consent
✓. Appropriate candidate for neurointerventional procedure
✓. Able and willing to access all clinical testing and not impeded by geographical location
✓. Proficient in English
✓. Have a study partner
Exclusion criteria
✕. Active condition resulting in immunosuppression